SELECT MEDICAL HOLDINGS CORP
SEM Real Time Price USDRecent trades of SEM by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Jim Cooper House / D | Sale $1,001 - $15,000 | Aug. 06, 2014 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SEM's directors and management
Government lobbying spending instances
-
$520,000 Oct 15, 2024 Issue: Medicare/Medicaid Health Issues
-
$600,000 Jul 18, 2024 Issue: Medicare/Medicaid Health Issues
-
$740,000 Apr 17, 2024 Issue: Medicare/Medicaid Health Issues
-
$1,180,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$480,000 Oct 13, 2023 Issue: Medicare/Medicaid Health Issues
-
$490,000 Jul 17, 2023 Issue: Medicare/Medicaid Health Issues
-
$940,000 Jan 17, 2023 Issue: Medicare/Medicaid Health Issues
-
$490,000 Oct 17, 2022 Issue: Medicare/Medicaid Health Issues
-
$430,000 Jul 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$770,000 Apr 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$1,240,000 Jan 19, 2022 Issue: Medicare/Medicaid Health Issues
-
$290,000 Oct 15, 2021 Issue: Health Issues Medicare/Medicaid
-
$310,000 Jul 19, 2021 Issue: Health Issues Medicare/Medicaid
-
$560,000 Apr 16, 2021 Issue: Health Issues Medicare/Medicaid
-
$990,000 Jan 19, 2021 Issue: Health Issues Medicare/Medicaid
-
$390,000 Oct 15, 2020 Issue: Medicare/Medicaid Health Issues
-
$360,000 Jul 15, 2020 Issue: Health Issues Medicare/Medicaid
-
$650,000 Apr 14, 2020 Issue: Medicare/Medicaid Health Issues
-
$750,000 Jan 15, 2020 Issue: Medicare/Medicaid Health Issues
-
$350,000 Oct 16, 2019 Issue: Health Issues Medicare/Medicaid
-
$320,000 Jul 18, 2019 Issue: Health Issues Medicare/Medicaid
-
$530,000 Apr 17, 2019 Issue: Medicare/Medicaid Health Issues
-
$740,000 Jan 16, 2019 Issue: Medicare/Medicaid Health Issues
-
$290,000 Oct 17, 2018 Issue: Health Issues Medicare/Medicaid
-
$540,000 Jul 16, 2018 Issue: Medicare/Medicaid Health Issues
-
$590,000 Apr 18, 2018 Issue: Medicare/Medicaid Health Issues
-
$810,000 Jan 18, 2018 Issue: Medicare/Medicaid Health Issues
-
$380,000 Oct 16, 2017 Issue: Medicare/Medicaid Health Issues
-
$420,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$830,000 Apr 19, 2017 Issue: Medicare/Medicaid Health Issues
-
$310,000 Jan 19, 2017 Issue: Health Issues Medicare/Medicaid
-
$310,000 Oct 18, 2016 Issue: Medicare/Medicaid Health Issues
-
$250,000 Jul 19, 2016 Issue: Medicare/Medicaid Health Issues
-
$440,000 Apr 19, 2016 Issue: Health Issues Medicare/Medicaid
-
$540,000 Jan 14, 2016 Issue: Health Issues Medicare/Medicaid
-
$280,000 Oct 13, 2015 Issue: Health Issues Medicare/Medicaid
-
$260,000 Jul 15, 2015 Issue: Medicare/Medicaid Health Issues
-
$700,000 Apr 20, 2015 Issue: Medicare/Medicaid Health Issues
-
$720,000 Jan 19, 2015 Issue: Medicare/Medicaid Health Issues
-
$410,000 Oct 20, 2014 Issue: Medicare/Medicaid Health Issues
-
$460,000 Jul 21, 2014 Issue: Health Issues Medicare/Medicaid
-
$720,000 Apr 18, 2014 Issue: Medicare/Medicaid Health Issues
-
$2,153,410 Jan 17, 2014 Issue: Health Issues Medicare/Medicaid
-
$410,000 Oct 21, 2013 Issue: Medicare/Medicaid Health Issues
-
$360,000 Jul 23, 2013 Issue: Medicare/Medicaid Health Issues
-
$360,000 May 24, 2013 Issue: Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SEM in WallStreetBets Daily Discussion
Recent insights relating to SEM
Recent picks made for SEM stock on CNBC
ETFs with the largest estimated holdings in SEM
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SEM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.